Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro

Nature Methods

Volumn 13, Issue 2, 2016, Pages 151-157

  Benam, Kambez H ^a   Villenave, Remi ^a   Lucchesi, Carolina ^a,g   Varone, Antonio ^a,g   Hubeau, Cedric ^b   Lee, Hyun Hee ^c   Alves, Stephen E ^c   Salmon, Michael ^c   Ferrante, Thomas C ^a   Weaver, James C ^a,d   Bahinski, Anthony ^a   Hamilton, Geraldine A ^a,g   Ingber, Donald E ^a,d,e,f  

^a HARVARD UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d HARVARD UNIVERSITY   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Emulate Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13;

DRUG EFFECTS; EPITHELIUM; HUMAN; INFLAMMATION; LAB ON A CHIP; LUNG DISEASES; METABOLISM; PATHOLOGY; TISSUE CULTURE TECHNIQUE;

EPITHELIUM; HUMANS; INFLAMMATION; INTERLEUKIN-13; LAB-ON-A-CHIP DEVICES; LUNG DISEASES; TISSUE CULTURE TECHNIQUES;

EID: 84956654664     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3697     Document Type: Article

References (53)

1. World Health Organization. Top 10 causes of death http://www.who.int/mediacentre/factsheets/fs310/en/ (2014).
2. Bafadhel, M.. et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 184, 662-671 (2011).
3. Jackson, D.J., Sykes, A., Mallia, P. & Johnston, S.L. Asthma exacerbations: origin, effect, and prevention. J. Allergy Clin. Immunol. 128, 1165-1174 (2011).
4. Hyde, D.M., Hamid, Q. & Irvin, C.G. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 124 (suppl. 6), S72-S77 (2009).
5. Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175 (2013).
6. Wright, J.L., Cosio, M. & Churg, A. Animal models of chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L1-L15 (2008).
7. Di Stefano, A. et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 158, 1277-1285 (1998).
8. Fahy, J.V. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc. Am. Thorac. Soc. 6, 256-259 (2009).
9. Hogg, J.C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653 (2004).
10. Bueters, T., Ploeger, B.A. & Visser, S.A. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives. Drug Discov. Today 18, 853-862 (2013).
11. Fulcher, M.L., Gabriel, S., Burns, K.A., Yankaskas, J.R. & Randell, S.H. Well-differentiated human airway epithelial cell cultures. Methods Mol. Med. 107, 183-206 (2005).
12. Ugonna, K., Bingle, C.D., Plant, K., Wilson, K. & Everard, M.L. Macrophages are required for dendritic cell uptake of respiratory syncytial virus from an infected epithelium. PLoS ONE 9, e91855 (2014).
13. Didierlaurent, A. et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205, 323-329 (2008).
14. Hammad, H. et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15, 410-416 (2009).
15. Teijaro, J.R. et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980-991 (2011).
16. Langer, H.F. & Chavakis, T. Leukocyte-endothelial interactions in inflammation. J. Cell. Mol. Med. 13, 1211-1220 (2009).
17. Bhatia, S.N. & Ingber, D.E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760-772 (2014).
18. Esch, E.W., Bahinski, A. & Huh, D. Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 14, 248-260 (2015).
19. Huh, D. et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 159ra147 (2012).
20. Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
21. Wanner, A., Salathe, M. & O'Riordan, T.G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154, 1868-1902 (1996).
22. Fliegauf, M., Benzing, T. & Omran, H. When cilia go bad: cilia defects and ciliopathies. Nat. Rev. Mol. Cell Biol. 8, 880-893 (2007).
23. Livraghi, A. & Randell, S.H. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol. Pathol. 35, 116-129 (2007).
24. Wills-Karp, M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175-190 (2004).
25. Kuperman, D.A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885-889 (2002).
26. Danahay, H. et al. Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung. Cell Rep. 10, 239-252 (2015).
27. Sousa, A.R., Poston, R.N., Lane, S.J., Nakhosteen, J.A. & Lee, T.H. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147, 1557-1561 (1993).
28. Ordoñez, C.L. et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 163, 517-523 (2001).
29. Thomas, B. et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J. Allergy Clin. Immunol. 126, 722-729 (2010).
30. Hewson, C.A., Jardine, A., Edwards, M.R., Laza-Stanca, V. & Johnston, S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 79, 12273-12279 (2005).
31. Curradi, G. et al. Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells. Cell. Mol. Life Sci. 69, 2217-2231 (2012).
32. Ding, B.S., Gomi, K., Rafii, S., Crystal, R.G. & Walters, M.S. Endothelial MMP14 is required for endothelial-dependent growth support of human airway basal cells. J. Cell Sci. 128, 2983-2988 (2015).
33. Lawrence, M.B. & Springer, T.A. Neutrophils roll on E-selectin. J. Immunol. 151, 6338-6346 (1993).
34. Mayer, A.K. et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 178, 3134-3142 (2007).
35. O'Shaughnessy, T.C., Ansari, T.W., Barnes, N.C. & Jeffery, P.K. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am. J. Respir. Crit. Care Med. 155, 852-857 (1997).
36. Papi, A. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 173, 1114-1121 (2006).
37. Deslee, G. et al. Bronchial epithelial spheroids: an alternative culture model to investigate epithelium inflammation-mediated COPD. Respir. Res. 8, 86 (2007).
38. Fleischmann, R. et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367, 495-507 (2012).
39. Bush, A. et al. Severe childhood asthma: a common international approach? Lancet 372, 1019-1021 (2008).
40. Kudlacz, E., Conklyn, M., Andresen, C., Whitney-Pickett, C. & Changelian, P. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. Eur. J. Pharmacol. 582, 154-161 (2008).
41. Ammit, A.J. Glucocorticoid insensitivity as a source of drug targets for respiratory disease. Curr. Opin. Pharmacol. 13, 370-376 (2013).
42. Wu, J. et al. Design and chemoproteomic functional characterization of a chemical probe targeted to bromodomains of BET family proteins. Medchemcomm 5, 1871-1878 (2014).
43. Belkina, A.C., Nikolajczyk, B.S. & Denis, G.V. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J. Immunol. 190, 3670-3678 (2013).
44. Abbassi, O., Kishimoto, T.K., McIntire, L.V., Anderson, D.C. & Smith, C.W. E-selectin supports neutrophil rolling in vitro under conditions of flow. J. Clin. Invest. 92, 2719-2730 (1993).
45. Gomez-Cambronero, J., Horn, J., Paul, C.C. & Baumann, M.A. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway. J. Immunol. 171, 6846-6855 (2003).
46. Hubeau, C., Kubera, J.E., Masek-Hammerman, K. & Williams, C.M. Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C). Clin. Sci. (Lond.) 125, 483-493 (2013).
47. Sellgren, K.L., Butala, E.J., Gilmour, B.P., Randell, S.H. & Grego, S. A biomimetic multicellular model of the airways using primary human cells. Lab Chip 14, 3349-3358 (2014).
48. Boers, J.E., Ambergen, A.W. & Thunnissen, F.B. Number and proliferation of clara cells in normal human airway epithelium. Am. J. Respir. Crit. Care Med. 159, 1585-1591 (1999).
49. Mercer, R.R., Russell, M.L., Roggli, V.L. & Crapo, J.D. Cell number and distribution in human and rat airways. Am. J. Respir. Cell Mol. Biol. 10, 613-624 (1994).
50. Villenave, R. et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. USA 109, 5040-5045 (2012).
51. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408 (2001).
52. Benam, K.H., Kok, W.L., McMichael, A.J. & Ho, L.P. Alternative spliced CD1d transcripts in human bronchial epithelial cells. PLoS ONE 6, e22726 (2011).
53. Kitagawa, S., Takaku, F. & Sakamoto, S. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. J. Clin. Invest. 65, 74-81 (1980).